Comments on “The SCM Test for Cancer. An Evaluation in Terms of Lymphocytes from Healthy Donors and Cancer Patients” by Bagshawe, K. D. et al.
LETTERS TO THE EDITOR 949
KREUTZMANN, H., FLIEDNER, T. M., GALLA, H. J. &
SACKMANN, E. (1978) Fluorescence-polarization
changes in mononuclear blood leucocytes after
PHA incubation: Differences in cells from patients
with and without neoplasia. Br. J. Cancer, 37, 797.
PRITCHARD, J. A. V., SEAMAN, J. E., DAVIES, B. H.
& 6 others (1978) Cancer specific density changes
in lymphocytes following stimulation with phyto-
haemagglutinin. Lancet, ii, 1275.
PRITCHARD, J. A. V. & SUTHERLAND, W. H. (1978)
Lymphocyte response to antigen stimulation as
measured by fluorescence polarization (SCM test).
Br. J. Cancer, 38, 339.
0RJASAETER, H., JORDFALD, G. & SVENDSEN, I.
(1979) Response of T lymphocytes to phyto-
haemagglutinin (PHA) and to cancer-tissue-asso-
ciated antigens, measured by the intracellular
fluorescence polarization technique (SCM test).
Br. J. Cancer, 40, 628.
TAKAKU, F., YAMANAKA, T. & HASIIMOTO, Y. (1977)
Usefulness of the SCM test in the diagnosis of
gastric cancer. Br. J. Cancer, 36, 810.
WEBER, G. (1952) Polarisation of the fluorescence of
macromolecules. Biochem. J., 51, 145.
SIR,-We thank Drs L. & B. Cercek for
their comments. It is, we agree, debatable
whether we established "the SCM test",
though 12 man-years were spent trying to
establish it by following the described pro-
cedures; an unlikely indulgence had our
motivation been bias.
Lymphocyte preparation was performed as
described and 2 distinct layers were obtained
in - 70% ofoccasions. As indicated in Tables
II, III and IV of our paper, 92-99%/' of the
upper-layer cells were lymphocytes with T:B
ratio ofthe order of4:1, so that , 75% ofthe
upper layer were T cells. The rosetting tech-
niques we used required 4 sheep erythrocytes
to attach to the lymphocytes, and this may
have underestimated the T-cell population by
more recent criteria.
Cercek & Cercek cite 0rjasaeter et al. (1979)
as demonstrating that T cells are the re-
sponders in the SCM test, but we note that
these authors used a pure T-cell suspension
obtained by a different method, because "the
separation procedure of Cercek & Cercek
(1977) gave inconsistent results in our hands".
On the question ofstray-light artefacts it is
appropriate to point out that the MPF-4
instrument we used was the one on which the
Cerceks successfully demonstrated themethod
at the 1976 Charing Cross Workshop.
The fact is that we have not been able to
substantiate the original claim for a cancer
test with the high order ofreliability required
for clinical usefulness. Nor, it seems, are we
alone, since the 565/575 correct diagnoses
reported by Cercek & Cercek (1977) with a
method that needed "clarification and more
research" is now supported after much fur-
ther research by 88% correct results on 51
patients in a study with an unpublished
protocol. We are also unaware of any other
laboratory reporting significant results with
the SCM procedure in its original or modified
(1977) form.
11 September 1980
K. D. BAGSHAWE
C. R. PENTYCROSS
H. MITCHELL
Department ofMedical Oncology, Charing Cross
Hospital Medical School, London